NDSClass II
Media, Culture, Ex Vivo, Tissue And Cell
21 CFR 876.5885 / Gastroenterology, Urology
NDS is the FDA product code for Media, Culture, Ex Vivo, Tissue And Cell, a class II device type, regulated under 21 CFR 876.5885. As of , FDA records hold 9 510(k) clearances under this code, the most recent dated , and 7 recalls.
Classification record
- Product code
- NDS
- Device name
- Media, Culture, Ex Vivo, Tissue And Cell
- Regulation
- 21 CFR 876.5885
- Device class
- Class II
- Review panel
- Gastroenterology, Urology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 9
- Ingested recalls
- 7
Clearances, product code NDS
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Applicants with the most clearances
Product code NDS| Applicant | Clearances |
|---|---|
| Life Technologies Corporation | 4 |
| Duogenic Stemcells Corporation | 1 |
| Energy Delivery Solutions | 1 |
| FUJIFILM Biosciences Inc. | 1 |
| Invitrogen Corporation | 1 |
| Yocon Biology Technology Company | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
